Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
3D multi-omics platform for genetically validated drug target discovery
Enhanced Genomics is a biotechnology company developing a proprietary 3D multi-omics platform that maps genome-wide chromatin interactions to identify genetically validated drug…
First-in-class small molecule therapeutics targeting DNA uracilation in cancer
CV6 Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule drugs for cancer and inflammatory diseases. Its lead asset CV6-168 is a…
Stem cell platform for precision psychiatry and drug discovery
MeOmics Precision Medicine is a biotechnology company developing a precision psychiatry platform that combines genomics, phenomics, and stem cell-based cellular assays to generate…
Bioanalytical instruments and automation for drug discovery research
Molecular Devices is a provider of high-performance bioanalytical measurement instruments, software, and consumables for life science research and pharmaceutical development. The…
High-performance counter-current chromatography instruments and services
Dynamic Extractions is a Welsh instruments and contract services company specialising in the design, manufacture, and application of High Performance Counter Current…
First-in-class small molecule inhibitors of RNA-modifying enzymes
STORM Therapeutics is a clinical-stage biotechnology company pioneering the field of RNA epigenetics, developing small molecule inhibitors of RNA-modifying enzymes as a new class…
Targeted protein degradation platform for neurodegenerative disease
TRIMTECH Therapeutics is a biotechnology company developing small-molecule degraders that selectively remove disease-causing protein aggregates while preserving the functional,…
Extracellular vesicle platform for consistent, scalable regenerative therapeutics
Mesenbio is a preclinical-stage biopharmaceutical company developing a cell line platform that produces a consistent, scalable supply of therapeutic extracellular vesicles,…
TCR bispecific immunotherapies for cancer and infectious disease
Immunocore is a commercial-stage biopharma developing T cell receptor bispecific immunotherapies. Its lead product tebentafusp received FDA approval in 2022 for metastatic uveal…
Oncology drug discovery and IP licensing from rural Wales
Morvus Technology is a privately owned pharmaceutical company engaged in the discovery, development, and out-licensing of novel oncology drugs and platform technologies. The…
AI-designed antibody biologics adapting human therapeutics for companion animals
Antigenesis Biologics is a biotechnology company developing targeted biological treatments for companion animals, applying expertise in human antibody therapeutics to address a…
Tunable covalent chemistry platform for neurodegenerative disease
Dunad Therapeutics is a drug discovery biotech developing small molecule therapies for neurodegenerative diseases including ALS, frontotemporal dementia, and Parkinson's disease.…